Creating cell banks for vaccine production to prepare for pandemics
Official title: Task V26: MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS
Funded at Idt Biologika Gmbh · NIH-10267379 · Data updated 2026-11-12
This study is all about creating and testing special cell banks that help make vaccines for infectious diseases, so we can be better prepared for future outbreaks and keep everyone safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Idt Biologika Gmbh NIH-funded |
| Lab location | 1 site (Dessau-Rosslau, Germany) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2020 |
| Award (this year) | $541,627 |
| NIH project number | 272201800011I-0-759302000002-2 |
| Project ID | NIH-10267379 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk of infectious diseases, particularly during pandemic situations.
✕Less likely to help
Patients who are not at risk for infectious diseases or those who do not receive vaccines may not benefit from this research.
What this research studies
This research focuses on the manufacturing and characterization of cell banks that are essential for developing vaccines against infectious diseases, particularly in response to potential pandemics. It involves planning and optimizing vaccine production processes, ensuring compliance with regulatory standards, and providing support for clinical studies. By establishing a robust infrastructure for vaccine development, this project aims to enhance the readiness for emerging infectious threats.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective vaccine production during pandemics, ultimately saving lives.
How similar studies have gone: Previous research has shown success in vaccine development and manufacturing processes, indicating that this approach is grounded in established methodologies.
Where this research is happening
-
Idt Biologika Gmbh
Dessau-Rosslau, Germany Active
Researchers
- Principal investigator: Neubert, Andreas — Idt Biologika Gmbh
- Study coordinator: Neubert, Andreas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.